The COVID-19 pandemic has devastated communities throughout the world. However, the negative impacts of another pandemic, affecting cities worldwide, arguably rival those of COVID.
Background: Combustion-related nitrogen dioxide (NO2) air pollution is associated with paediatric asthma incidence.
Background: Effectiveness of health programmes can be undermined when the implementation misaligns with local beliefs and behaviours.
Background: Hepatitis C elimination may be possible with broad uptake of direct-acting antiviral treatments (DAAs).
Elsevier,
Biomedical Engineering Applications for People with Disabilities and the Elderly in the COVID-19 Pandemic and Beyond, Volume , 1 January 2022
This content aligns with Goal 3: Good Health and Wellbeing as well as Goal 10: Reducing Inequalities by examining the impact of the COVID-19 pandemic on the physical and mental health of the elderly.
This content aligns with Goal 3: Good Health and Wellbeing as well as Goal 10: Reducing Inequalities by exploring herbal medicines role in depression to provide alternatives to current psychiatric drugs which may cause many induced side effects.
This content aligns with Goal 3: Good Health and Wellbeing as well as Goal 10: Reducing Inequalities by providing different levels and magnitude of explanation for the various behavioral symptoms seen in individuals with ASD, collectively providing a comprehensive picture of this disorder.
Elsevier,
Managing Treatment-Resistant Depression: Road to Novel Therapeutics, Volume , 1 January 2022
This content aligns with Goal 3: Good Health and Wellbeing as well as Goal 10: Reducing Inequalities by reviewing the evidence base for treatment of youth with depression, with a focus on management of treatment-resistant depression.
Elsevier,
Managing Treatment-Resistant Depression: Road to Novel Therapeutics, Volume , 1 January 2022
This content aligns with Goal 3: Good Health and Wellbeing as well as Goal 10: Reducing Inequalities by exploring novel and advanced personalized medicine approaches to tailor depression treatments.
Elsevier,
Managing Treatment-Resistant Depression: Road to Novel Therapeutics, Volume , 1 January 2022
This content aligns with Goal 3: Good Health and Wellbeing as well as Goal 10: Reducing Inequalities by reviewing the data on clinical and epidemiological predictors of antidepressant response, or predictors of treatment-resistant depression and discussing the possible prognostic value of clinical features, like severity, chronicity, subtypes of depression, comorbidities, history of trauma, and epidemiological features like gender, age, sociodemographic status.
